Literature DB >> 19094159

Aggrenox (Asasantin retard)-induced Stevens-Johnson syndrome.

Tun Jao, Tsung-Hua Tsai, Jiann-Shing Jeng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19094159      PMCID： PMC2670386          DOI： 10.1111/j.1365-2125.2008.03340.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

2.  A case of toxic epidermal necrolysis with involvement of the GI tract after systemic contrast agent application at cardiac catheterization.

Authors:  Austin Garza; Adam J Waldman; Jay Mamel
Journal:  Gastrointest Endosc       Date:  2005-10       Impact factor: 9.427

Review 3.  Severe adverse cutaneous reactions to drugs.

Authors:  J C Roujeau; R S Stern
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Acetylsalicylic acid and other salicylates in relation to Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  D W Kaufman; J P Kelly
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

Review 6.  8. Drug allergy.

Authors:  Paul A Greenberger
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

7.  Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.

Authors:  P H A Halkes; J van Gijn; L J Kappelle; P J Koudstaal; A Algra
Journal:  Lancet       Date:  2006-05-20       Impact factor: 79.321

Review 8.  Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.

Authors:  Erik Letko; Dean N Papaliodis; George N Papaliodis; Yassine J Daoud; A Razzaque Ahmed; C Stephen Foster
Journal:  Ann Allergy Asthma Immunol       Date:  2005-04       Impact factor: 6.347

9.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

10.  Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

Authors:  J C Roujeau; J P Kelly; L Naldi; B Rzany; R S Stern; T Anderson; A Auquier; S Bastuji-Garin; O Correia; F Locati
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245
View more
  5 in total

1.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.

Authors:  Noel Frey; Michael Bodmer; Andreas Bircher; Susan S Jick; Christoph R Meier; Julia Spoendlin
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

2.  First case of Stevens-Johnson syndrome after rabies vaccination.

Authors:  Li Ma; Xusheng Du; Yu Dong; Lirong Peng; Xiaonian Han; Jianhua Lyu; Hehe Bai
Journal:  Br J Clin Pharmacol       Date:  2018-02-09       Impact factor: 4.335

Review 3.  Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs.

Authors:  Kathrin Scherer Hofmeier
Journal:  Allergo J Int       Date:  2015-03-14

Review 4.  Stevens - Johnson Syndrome and Toxic Epidermal Necrolysis; Extensive Review of Reports of Drug-Induced Etiologies, and Possible Therapeutic Modalities.

Authors:  Adegbenro Omotuyi John Fakoya; Princess Omenyi; Precious Anthony; Favour Anthony; Precious Etti; David Adeiza Otohinoyi; Esther Olunu
Journal:  Open Access Maced J Med Sci       Date:  2018-03-28

5.  Stevens-Johnson syndrome induced by a combination of lamotrigine and valproic acid.

Authors:  S Kavitha; T Anbuchelvan; V Mahalakshmi; R Sathya; T R Sabarinath; N Gururaj; S Kalaivani
Journal:  J Pharm Bioallied Sci       Date:  2015-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.